Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
Early detection of ovarian cancer has been a challenge to manage the high mortality rate caused by this deadly disease. The trends in mortality have been reduced by the scientific contributions from the corners across the globe, however accounting for the fifth leading cause of gynecological mortali...
Main Authors: | Thingreila Muinao, Hari Prasanna Deka Boruah, Mintu Pal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844019364862 |
Similar Items
-
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
by: Ana Alcaraz-Sanabria, et al.
Published: (2020-01-01) -
Platelet protein biomarker panel for ovarian cancer diagnosis
by: Marta Lomnytska, et al.
Published: (2018-01-01) -
High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer
by: Francis Jacob, et al.
Published: (2021-01-01) -
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer
by: Anna Adam-Artigues, et al.
Published: (2021-06-01) -
Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
by: Zhan XH, et al.
Published: (2017-06-01)